Ebima Clifford Okundaye
Clinical trials sponsored by Ebima Clifford Okundaye, explained in plain language.
-
New pill aims to keep kidneys working longer in millions with CKD
Disease control Not yet recruitingThis study tests a new drug, QRX3, in 3,000 adults with chronic kidney disease (CKD) whose kidney function is declining. The goal is to see if QRX3 can slow that decline and reduce protein in the urine. Participants must have an eGFR below 60 and a slow rate of decline (less than…
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New drug QRX-3 aims to speed kidney recovery in acute failure patients
Disease control Not yet recruitingThis study tests whether the investigational drug QRX-3 can help hospitalized children and adults with acute tubular necrosis, a type of sudden kidney failure. About 500 participants will receive either QRX-3 or a placebo alongside standard care. The main goal is to see if QRX-3 …
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated May 18, 2026 12:04 UTC